Bay Area may be at risk from synthetic biology research labs
By Emily Smith Beitiks,
San Jose Mercury News
| 03. 27. 2012
Lawrence Berkeley National Laboratory recently announced a proposal to build a facility in Richmond at which synthetic biology research will be a major focus. This news should give us pause to consider exactly what risks this little-known field poses for the environment and human health.
Last year, molecular biologist Becky McClain was awarded $1.37 million in a whistle-blower suit against the pharmaceutical giant Pfizer after she was fired for raising safety concerns about the lab where she worked. McClain was infected with a genetically engineered virus being researched in her lab. She continues to experience intermittent paralysis and spinal pain, symptoms consistent with the effects of the pathogen.
McClain's story offers an important lesson for assessing a new kind of bioengineering: the rapidly growing field of synthetic biology, which has already been called genetic engineering on steroids.
Synthetic biologists build artificial organisms using the building blocks of life. While techniques vary, the intent is the same: to create life from scratch. Proponents promise extraordinary benefits, from curing diseases to replacing fossil fuels. But the unknowns are as serious as they...
Related Articles
By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...
By Anna Louie Sussman, The New York Times | 07.01.2026
Birthrates in much of the developed world are at record lows, but there’s one demographic group that’s exploring new frontiers of fertility: ultrawealthy men. Deploying nearly limitless resources, a small number of them are reproducing at such an extraordinary scale...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...